Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.

Drug use ups risk of HCV reinfection

04 Apr 2020

Injecting drugs appears to elevate the risk of hepatitis C virus (HCV) reinfection among those who had already been treated, reports a new meta-analysis.

Accessing the databases of PubMed, Scopus, Web of Science, CENTRAL and PsycINFO, researchers retrieved 36 studies corresponding to 6,331 person-years of follow-up. Thirty-three studies provided information about injecting and noninjecting drugs, 31 had data on injected drugs alone, and 25 studies included patients who had taken opioid agonist therapies (OATs).

HCV reinfection was higher among those with recent drug use. In patients who used injecting and noninjecting drugs, the rate of reinfection was 5.9 per 100 person-years; in those who were injecting users, reinfection occurred at a rate of 6.2 per 100 person-years.

In comparison, those who were taking OATs had a lower HCV reinfection rate, at 3.8 per 100 person-years.

A similar trend was reported for persistent HCV reinfection. Pooled rates from 24 studies were 5.1, 5.4 ad 3.4 per 100 person-years in recent drug users, recent injecting users and those on OAT.

Meta-regression analysis further showed that in patients on OAT, concomitant recent drug use more than tripled the risk of HCV reinfection (adjusted rate ratio [RR], 3.50, 95 percent confidence interval [CI], 1.62–7.53; p=0.002). Notably, the risk was even higher among patients with recent drug use but who were not on OAT (adjusted RR, 3.96, 95 percent CI, 1.82–8.59; p=0.001).

“Monitoring HCV reinfection following successful HCV treatment in people who inject drugs will be crucial to HCV elimination efforts,” the researchers said. “Further studies are required to evaluate innovative strategies and models of care to enhance engagement in post-treatment care and prevent HCV reinfection among people who inject drugs.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.